Clinical Trials

240 enrolled

Anxiety Disorders

NCT03753659 2026-03-23

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

30 enrolled 10 charts

Phase 2 Active not recruiting

Carcinoma, Hepatocellular

NCT04318938 2026-03-02

Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping

118 enrolled

Thoracic

NSCLC

NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

250 enrolled

Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

NCT06690775 2025-12-23

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Phase 2 Active not recruiting

230 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT04238637 2025-12-05

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

50 enrolled

Cholangiocarcinoma

NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

20 enrolled

BRAF V600 Colorectal Cancer

NCT06207734 2025-05-01

Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer

120 enrolled

Breast

Breast Neoplasms

NCT01973322 2025-01-09

ABSIDE

34 enrolled

Dermatologic

Melanoma

NCT04760327 2024-10-17

GynECT

30 enrolled

Gynecological Cancers

NCT00596154 2024-04-01

PCNSL

33 enrolled 9 charts

Lymphoid

Lymphoma, Non-Hodgkin

NCT00318903 2023-05-25

Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer

25 enrolled

Esophageal Neoplasms

NCT03841201 2023-05-12

Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma

50 enrolled

Carcinoma, Hepatocellular

NCT03698227 2020-07-15

OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients

2 enrolled

Sarcoma

NCT01891357 2019-09-17

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

64 enrolled 7 charts

Breast

Carcinoma, Ductal, Breast

NCT00526656 2019-04-16

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

9 enrolled 5 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00547157 2017-03-15

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

152 enrolled 18 charts

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT03048123 2017-02-09

HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B

79 enrolled

Carcinoma, Hepatocellular

NCT00210392 2015-03-30

VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy

12 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT00203879 2013-09-05

Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma

19 enrolled

Dermatologic

Melanoma

NCT00210327 2009-07-22

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

33 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT00167908 2009-02-04

Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

27 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00695370 2008-06-13

Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children

30 enrolled

Tumor-Agnostic

Neoplasms

NCT00319007 2007-08-10

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Phase 2 Unknown

30 enrolled